Zacks Research Expects Stronger Earnings for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Analysts at Zacks Research upped their Q2 2025 earnings per share (EPS) estimates for shares of Teladoc Health in a research report issued to clients and investors on Wednesday, May 14th. Zacks Research analyst R. Department now expects that the health services provider will post earnings per share of ($0.26) for the quarter, up from their previous forecast of ($0.28). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health's Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.74) EPS, Q1 2026 earnings at ($0.34) EPS, Q2 2026 earnings at ($0.20) EPS, Q3 2026 earnings at ($0.22) EPS, Q4 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.86) EPS, Q1 2027 earnings at ($0.29) EPS and FY2027 earnings at ($0.85) EPS.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million.

Several other equities research analysts have also recently commented on TDOC. Jefferies Financial Group decreased their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Stifel Nicolaus dropped their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. Royal Bank of Canada increased their price target on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Finally, Evercore ISI decreased their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a research report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $9.71.

Teladoc Health Trading Up 3.8%

TDOC opened at $7.52 on Monday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.32 billion, a PE ratio of -1.30 and a beta of 1.82. The company has a fifty day moving average of $7.58 and a 200-day moving average of $9.37. Teladoc Health has a twelve month low of $6.35 and a twelve month high of $15.21.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Whipplewood Advisors LLC bought a new stake in Teladoc Health in the 4th quarter worth approximately $29,000. Golden State Wealth Management LLC boosted its holdings in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the period. National Bank of Canada FI grew its stake in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. Lindbrook Capital LLC grew its stake in shares of Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Finally, SVB Wealth LLC purchased a new position in Teladoc Health during the 1st quarter valued at about $37,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This represents a 14.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.58% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.